¹³C-urea breath test for diagnosis of Helicobacter pylori infection in the elderly

Medicine and Dentistry

• Urea Breath Test 100%
• Helicobacter Infection 100%
• Urea C 13 100%
• Helicobacter Pylori 50%
• Patient Referral 50%
• Diseases 50%
• Metronidazole 33%
• Geriatrics 33%
• Prevalence 16%
• Nonsteroid Antiinflammatory Agent 16%
• Cancer Therapy 16%
• Cohort Effect 16%
• Infection 16%
• Recurrent Disease 16%
• Proton-Pump Inhibitor 16%
• Carbon 13 16%
• Eradication Therapy 16%
• Multivariate Logistic Regression Analysis 16%
• Predictive Factor 16%
• Abdominal Cancer 16%

Keyphrases

• Helicobacter Pylori Infection 100%
• Urea Breath Test 100%
• Peptic Disease 50%
• Israeli 33%
• Helicobacter Pylori (H. pylori) 33%
• High Prevalence 16%
• Proton Pump Inhibitors 16%
• Non-steroidal Anti-inflammatory Drugs (NSAIDs) 16%
• Demographic Data 16%
• Predictive Factors 16%
• Well-defined 16%
• Logistic Regression Analysis 16%
• Metronidazole 16%
• Treatment Combination 16%
• Eradication Therapy 16%
• Urea 16%
• Referral Patterns 16%
• Chronic Use 16%
• Treatment Results 16%
• Cohort Effect 16%
• Inflammatory Subtype 16%
• Metronidazole Resistance 16%
• Symptom Recurrence 16%
• Geriatric Population 16%
• Geriatric Patients 16%
• Gastric Cancer Surgery 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Helicobacter Infection 100%
• Urea Breath Test 100%
• Urea C 13 100%
• Helicobacter Pylori 50%
• Diseases 50%
• Metronidazole 33%
• Infection 16%
• Proton Pump Inhibitor 16%
• Non-Steroidal Anti-Inflammatory Drug 16%
• Prevalence 16%
• Recurrent Disease 16%
• Carbon 13 16%
• Abdominal Cancer 16%
• Epidemiology 16%